Exploring the Effects of Intrastriatal AAV5-miHTT-Lowering Therapy on Transcriptional Dysregulation, MRS Signal, and Mutant Huntingtin Levels in the Q175FDN Mouse Model of Huntington's Disease
Publication Date
12-18-2020
DOI
10.1007/S13311-020-00945-Z
ISSN
1933-7213
Recommended Citation
Leavitt, B., Stam, A., Brouwers, C., Petkau, T., Vermeulen, M., Yung, A., Russell-Schulz, B., Kozlowski, P., Mackay, A., Ma, D., Beg, F., Mostafavi, S., van Deventer, S., Evers, M. M., Konstantinova, P., & Valles, A. (2020). Exploring the Effects of Intrastriatal AAV5-miHTT-Lowering Therapy on Transcriptional Dysregulation, MRS Signal, and Mutant Huntingtin Levels in the Q175FDN Mouse Model of Huntington’s Disease. Neurotherapeutics, 17(SUPPL 1), S20. https://doi.org/10.1007/s13311-020-00945-z
COinS
